You are here

Mid-life and late-life vascular risk factor burden and neuropathology in old age.

TitleMid-life and late-life vascular risk factor burden and neuropathology in old age.
Publication TypeJournal Article
Year of Publication2019
AuthorsConner SC, Pase MP, Carneiro H, Raman MR, McKee AC, Alvarez VE, Walker JM, Satizabal CL, Himali JJ, Stein TD, Beiser A, Seshadri S
JournalAnn Clin Transl Neurol
Volume6
Issue12
Pagination2403-2412
Date Published2019 Dec
ISSN2328-9503
Abstract

OBJECTIVE: To determine whether vascular risk factor burden in mid- or late-life associates with postmortem vascular and neurodegenerative pathologies in a community-based sample.
METHODS: We studied participants from the Framingham Heart Study who participated in our voluntary brain bank program. Overall vascular risk factor burden was calculated using the Framingham Stroke Risk Profile (FSRP). Mid-life FSRP was measured at 50 to 60 years of age. Following death, brains were autopsied and semi-quantitatively assessed by board-certified neuropathologists for cerebrovascular outcomes (cortical infarcts, subcortical infarcts, atherosclerosis, arteriosclerosis) and Alzheimer's disease pathology (Braak stage, cerebral amyloid angiopathy, and neuritic plaque score). We estimated adjusted odds ratios between vascular risk burden (at mid-life and before death) and neuropathological outcomes using logistic and proportional-odds logistic models.
RESULTS: The median time interval between FSRP and death was 33.4 years for mid-life FSRP and 4.4 years for final FSRP measurement before death. Higher mid-life vascular risk burden was associated with increased odds of all cerebrovascular pathology, even with adjustment for vascular risk burden before death. Late-life vascular risk burden was associated with increased odds of cortical infarcts (OR [95% CI]: 1.04 [1.00, 1.08]) and arteriosclerosis stage (OR [95% CI]: 1.03 [1.00, 1.05]). Mid-life vascular risk burden was not associated with Alzheimer's disease pathology, though late-life vascular risk burden was associated with increased odds of higher Braak stage (OR [95% CI]: 1.03 [1.01, 1.05]).
INTERPRETATION: Mid-life vascular risk burden was predictive of cerebrovascular but not Alzheimer's disease neuropathology, even after adjustment for vascular risk factors before death.

DOI10.1002/acn3.50936
Pubmed Linkhttps://www.ncbi.nlm.nih.gov/pubmed/31691546?dopt=Abstract
page_expoExternal
Alternate JournalAnn Clin Transl Neurol
PubMed ID31691546
PubMed Central IDPMC6917310
Grant ListT32GM74905-14 / / National Institute of General Medical Sciences (NIGMS) /
F31HL145904-01 / / National Heart, Lung, and Blood Institute (NHLBI) /
T32HL125232-01A1 / / National Heart, Lung, and Blood Institute (NHLBI) /
N01-HC-25195 / / National Heart, Lung, and Blood Institute (NHLBI) /
HHSN268201500001I / HL / NHLBI NIH HHS / United States
75N92019D00031 / HL / NHLBI NIH HHS / United States
AARGD-16-443384 / / Alzheimer's Association / United States
102052 / / National Heart Foundation of Australia Future Leader Fellowship /
R01 AG054076 / AG / NIA NIH HHS / United States
R01 AG049607 / AG / NIA NIH HHS / United States
R01 AG033193 / AG / NIA NIH HHS / United States
U01 AG049505 / AG / NIA NIH HHS / United States
U01 AG052409 / AG / NIA NIH HHS / United States
RF1 AG054156 / AG / NIA NIH HHS / United States
NS017950 / NS / NINDS NIH HHS / United States
UH2 NS100605 / NS / NINDS NIH HHS / United States
HHSN268201500001I / HL / NHLBI NIH HHS / United States
R01 AG054076 / AG / NIA NIH HHS / United States
R01 AG049607 / AG / NIA NIH HHS / United States
R01 AG033193 / AG / NIA NIH HHS / United States
U01 AG049505 / AG / NIA NIH HHS / United States
U01 AG052409 / AG / NIA NIH HHS / United States
RF1 AG054156 / AG / NIA NIH HHS / United States
NS017950 / NS / NINDS NIH HHS / United States
UH2 NS100605 / NS / NINDS NIH HHS / United States

Theme by Danetsoft and Danang Probo Sayekti inspired by Maksimer